Profil
Currently, Dámaso Molero is the Chief Executive Officer at 3P Biopharmaceuticals SL since 2006.
Formerly, the roles included Principal at Shionogi & Co., Ltd., Syntex, Inc., Glaxo, Inc., and Roche Holding AG.
Education includes undergraduate and MBA degrees from the University of Navarra.
Aktiva positioner av Dámaso Molero
| Företag | Position | Start |
|---|---|---|
3P Biopharmaceuticals SL
3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins and biological molecules | Verkställande Direktör | 2007-04-01 |
Tidigare kända positioner av Dámaso Molero
| Företag | Position | Slut |
|---|---|---|
| SHIONOGI & CO., LTD. | Företagsledare/Principal | - |
| ROCHE HOLDING AG | Företagsledare/Principal | - |
Syntex, Inc.
Syntex, Inc. MiscellaneousMiscellaneous Operates as a non-classified establishment | Företagsledare/Principal | - |
Glaxo, Inc. | Företagsledare/Principal | - |
Dámaso Moleros utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Roche Holding AG
Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Shionogi & Co., Ltd.
Shionogi & Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the manufacturing and distribution of pharmaceuticals & diagnostic reagents | Health Technology |
University of Navarra
University of Navarra Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
3P Biopharmaceuticals SL
3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins and biological molecules | Health Technology |
Syntex, Inc.
Syntex, Inc. MiscellaneousMiscellaneous Operates as a non-classified establishment | Miscellaneous |
Glaxo, Inc. |
















